RENEE COURTEMANCHE: Open Payments
NPI 1265166615 · LEWISTON, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 42 payments from 19 companies in 2025. Trend: 2023 $815 · 2024 $832 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $248 |
| Janssen Biotech, Inc. | 5 | $111 |
| ABBVIE INC. | 4 | $101 |
| Astellas Pharma US Inc | 3 | $63 |
| PFIZER INC. | 3 | $60 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $51 |
| Exelixis Inc. | 2 | $45 |
| Syndax Pharmaceuticals, Inc. | 2 | $44 |
| ARRAY BIOPHARMA INC | 2 | $40 |
| Genentech USA, Inc. | 1 | $28 |
Products named: IMFINZI, TECVAYLI, LYNPARZA, PYLARIFY, ENHERTU, CABOMETYX, Xtandi, TAGRISSO.
Industry payments across ME — which companies pay providers there.
